Evidence map›Paper›PMID 27460364›Full record

ArticleStem cell research & therapy2016

Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer.

Ningning He, Guowei Feng, Yang Li, Yang Xu, Xiaoyan Xie, Hui Wang, Yuebing Wang, Lailiang Ou, Xuetao Pei, Na Liu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ningning HeSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, People's Republic of China.
Guowei FengDepartment of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, People's Republic of China.
Yang LiSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, People's Republic of China.
Yang XuSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, People's Republic of China.
Xiaoyan XieStem Cells and Regenerative Medicine Laboratory, Beijing Institute of Transfusion Medicine, Beijing, People's Republic of China.
Hui WangDepartment of Radiation Oncology, Tianjin Union Medical Center, Nankai University Affiliated Hospital, Tianjin, People's Republic of China.
Yuebing WangKey Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, People's Republic of China.
Lailiang OuKey Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, People's Republic of China.
Xuetao PeiStem Cells and Regenerative Medicine Laboratory, Beijing Institute of Transfusion Medicine, Beijing, People's Republic of China.
Na LiuSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, People's Republic of China. liuna@nankai.edu.cn.
Zongjin LiSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, People's Republic of China. zongjinli@nankai.edu.cn.
Nankai University · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicroenvironment is being increasingly recognized as a critical determinant in tumor progression and metastasis. However, the appropriate regulatory mechanism to maintain the normal balance between differentiation and self-renewal of the cancer cell in microenvironment is not well known.

methods4T1 breast cancer cells were treated with embryonic stem (ES) cell conditioned medium which was collected from mouse ES cells. Inhibition of tumor cell growth was based on the reduction of cell proliferation and viability, and inhibition of aggressive properties of tumor cells were examined using the wound-healing and mammosphere assays. The expression of stem cell-associated genes was detected by quantitative RT-PCR.

resultsWe used a real-time imaging system to investigate the effect of the mouse ES cell microenvironment on aggressive breast cancer cells in vitro and in vivo. Exposure of breast cancer cells in mouse ES cell conditioned medium resulted in inhibition of growth, migration, metastasis, and angiogenesis of cancer cells. For many tumors, aggressive properties were tightly related to Stat3 signaling activation. We specifically discovered that the ES cell microenvironment sufficiently suppressed Stat3 signaling pathway activation in aggressive tumor cells, leading to a reduction in tumorigenesis and invasiveness.

conclusionsWe identified important functions of Stat3 and their implications for antitumor effects of ES cell conditioned medium. Some factors secreted by ES cells could efficiently suppress Stat3 pathway activation in breast cancer cells, and were then involved in cancer cell growth, survival, invasion, and migration. This study may act as a platform to understand tumor cell plasticity and may offer new therapeutic strategies to inhibit breast cancer progression.

Indexed as

AnimalsBiological AssayCarcinogenesisCell DifferentiationCell ProliferationCell SurvivalCulture Media, ConditionedEmbryonic Stem CellsFeeder CellsFemaleGene ExpressionMammary Neoplasms, AnimalMiceMice, Inbred BALB CNeoplasm InvasivenessSignal TransductionCulture Media, ConditionedStat3 protein, mouseSTAT3 Transcription FactorBreast cancer cellsEmbryonic stem cellsImagingMicroenvironmentStat3 signaling

Identifiers

PMID27460364
PMCPMC4962384
OpenAlexW2487479128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.